Format

Send to

Choose Destination
Int J Clin Pharm. 2015 Oct;37(5):883-94. doi: 10.1007/s11096-015-0139-7. Epub 2015 May 28.

Development of a consensus-base list of criteria for prescribing medication in a pediatric population.

Author information

1
Pharmacy Practice Research Unit, Pharmacy Department, Sainte-Justine University Health Center, 3175, chemin de la Côte Sainte-Catherine, Montreal, Quebec, H3T 1C5, Canada. aurelieguerin01@gmail.com.
2
Pharmacy Department, Sainte-Justine University Health Center, Montreal, Quebec, Canada.
3
Faculty of Pharmacy, Université de Montréal, Montreal, Quebec, Canada.
4
Clinical Epidemiology Unit, APHP, Robert Debré University Health Center, 75019, Paris, France.
5
INSERM, U 1123 and CIC 1426, Robert Debré University Health Center, 75019, Paris, France.
6
Pharmacy Department, APHP, Robert Debré University Health Center, Paris, France.
7
Department of Clinical Pharmacy, Faculty of Pharmacy, Université Paris Descartes, Sorbonne Paris Cité, France.
8
Laboratory Education and Health Practices EA 3412, Université Paris 13, Sorbonne Paris Cité, France.
9
French Society of Clinical Pharmacy, Paris, France.

Abstract

BACKGROUND:

Although many people are involved in the optimal use of a medication within this process, the use of medications carries risks of adverse events, which are greater in the pediatric population because of many factors.

OBJECTIVE:

In this context, our aim was to develop a consensus-based list of criteria for the safety of the pediatric medication-use process or circuit (referred to from now on as the CIRCUS tool: CIRcuit-of-Child-drug-USe).

SETTING:

Multicenter with a trio of experts from eight university hospitals.

METHODS:

A literature search (1998-2013) was conducted in order to identify the different safety practice domains for the pediatric medication use process. Twenty-six safety practice domains were identified and 48 compliance criteria were formulated. In order to reach a consensus on the most relevant compliance criteria for safety practices, an international 24 French-speaking multidisciplinary panelists (8 doctors, 8 pharmacists and 8 nurses) selected to represent a broad range of experience levels and specialties took part in a two round Delphi survey which was conducted between March and July 2013. Each panelist was asked to rate each proposed criterion on a 1-9 Likert scale in order to show their level of agreement (i.e. 1 reflects strong disagreement and 9 reflects strong agreement).

MAIN OUTCOME MEASURE:

Development of a consensus-base list for safety practices in pediatrics.

RESULTS:

Twenty-two of the 24 professionals invited to take part in this survey (92% participation rate) completed the two Delphi rounds. At the end of the two Delphi rounds, a total of 38/48 (79%) safety practice compliance criteria achieved consensus by the panelists. The criteria were grouped into 23 domains.

CONCLUSION:

This study presents the development of a self-assessment tool for safety practices in the pediatric drug-use process using a Delphi method. This tool may be used in order to record and compare the prevalence of best safety practices in the pediatric drug-use process.

KEYWORDS:

Medication-use process; Patient safety; Pediatrics; Risk management; Self-assessment tool

PMID:
26017398
DOI:
10.1007/s11096-015-0139-7
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center